交易中 08-21 10:27:57 美东时间
-0.045
-0.77%
William Blair analyst Stephen Sheldon downgrades LegalZoom.com (NASDAQ:LZ) from Outperform to Market Perform.
08-07 01:42
LegalZoom.com shares are trading lower after the company reported worse-than-expected Q2 sales results. Also, the company lowered its FY2026 sales guidance below estimates.
08-06 05:02
LegalZoom.com (NASDAQ:LZ) sees Q3 sales of $192.000 million-$196.000 million vs $204.640 million analyst estimate.
08-06 04:03
LegalZoom.com (NASDAQ:LZ) lowers FY2026 sales outlook from $810.000 million-$830.000 million to $795.000 million-$805.000 million vs $821.999 million estimate.
08-06 04:03
As of July 16, 2026, three stocks in the industrials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices ...
07-16 20:45
LegalZoom, America’s leading online legal services platform, announced it will report its second-quarter 2026 financial results on August 5, 2026, after market close. CEO Jeff Stibel and CFO Noel Watson will host a conference call and webcast at 4:30 p.m. ET that day to discuss the results. The webcast and replay will be available on LegalZoom’s Investor Relations website. LegalZoom provides legal tools and guidance for individuals and small busi...
07-15 13:00
今日重点评级关注:Jones Trading:维持Definium Therapeutics"买入"评级,目标价从61美元升至74美元;韦德布什:维持Cerebras Systems"跑赢大市"评级,目标价从270美元升至280美元
06-25 11:32
JP Morgan analyst Ella Smith maintains LegalZoom.com (NASDAQ:LZ) with a Overweight and lowers the price target from $11 to $8.
06-24 23:08
Citigroup analyst Ronald Josey maintains LegalZoom.com (NASDAQ:LZ) with a Neutral and lowers the price target from $8.5 to $7.5.
05-22 23:18
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05